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Abstract The adaptor protein She was prepared as glutathione 
S-transferase fusion proteins (GST-She) and used as in vitro 
substrate for c-Src. Since phosphotyrosine-binding domain of 
She has been shown to bind phosphatidyl-inositol 4,5-bisphos-
phate (PtdIns(4,5)P2) [Zhou et al. (1995) Nature 378, 584-592], 
effect of PtdIns(4,5)P2 on the phosphorylation of GST-She by c-
Src was examined. PtdIns(4,5)P2 stimulated the phosphorylation 
of GST-She without any effect on the c-Src activity as judged by 
both its autophosphorylation and phosphorylation of exogenous 
substrate, Cdc2 peptide. On the other hand, phosphatidylserine, 
phosphatidic acid, phosphatidylinositol, and phosphatidylinositol 
4-phosphate but not phosphatidylcholine stimulated the c-Src 
activity itself. Km for GST-She in the presence of 1 JJM 
PtdIns(4,5)P2 was calculated to be 90 nM. The PtdIns(4,5)P2-
dependent phosphorylation of GST-She was inhibited by a GST-
fusion protein containing the phosphotyrosine-binding domain of 
She. These results suggest that PtdIns(4,5)P2 can act as a 
regulator of phosphorylation of She by c-Src through its binding 
to She. 
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1. Introduction 
For past several years, great attention has been paid to the 
intracellular signaling pathways provoked by cell surface re-
ceptor tyrosine kinases, such as growth factor receptors/kin-
ases. In these systems, protein tyrosine phosphorylation is 
established to play a pivotal role in the signaling events, 
such as Ras-dependent activation of the mitogen-activated 
protein kinase cascade. Recently, a number of receptors that 
lack intrinsic tyrosine kinase activity, such as heterotrimeric 
G-protein-coupled receptors and antigen receptors of T- and 
B-cells, have also been found to activate tyrosine kinase path-
ways [1]. In particular, it is well established that tyrosine 
phosphorylation of the adaptor protein She is indispensable 
in both kinase receptor and non-kinase receptor systems [2-5]. 
She exists in three isoforms: 46 kDa, 52 kDa, and 66 kDa. 
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These She molecules contain three structural and functional 
domains: an amino-terminal phosphotyrosine-binding (PTB) 
domain, a central collagen-homologous region containing a 
major tyrosine phosphorylation site, and a carboxyl-terminal 
Src homology 2 (SH2) domain. It has been suggested that 
activated receptor tyrosine kinases phosphorylate She directly, 
and phosphorylated She recruits an another SH2-containing 
adaptor protein Grb2 to the plasma membrane [2,6]. Grb2 
binds to a guanine nucleotide exchanging factor, Sos, that is 
directly responsible for the activation of Ras [2,6]. In case of 
non-kinase receptor systems, however, identity of the tyrosine 
kinases responsible for She phosphorylation has not yet been 
elucidated. Recently, it has been demonstrated that lysophos-
phatidic acid and angiotensin II, which act through the het-
erotrimeric G-protein-coupled receptors, cause functional and 
physical interaction between She and Src family tyrosine kin-
ases, such as c-Src and Fyn [7,8]. 
In the present study, we prepared glutathione S-transferase 
fusion proteins containing a full length of 46- or 52-kDa iso-
form of She (GST-She: GST-P46 and GST-P52), and phos-
phorylation of GST-She by c-Src was examined in a purified 
system. Since phosphotyrosine-binding domain of She has 
been shown to bind PtdIns(4,5)P2 [9], the effect of 
PtdIns(4,5)P2 and some other phospholipids on the phospho-
rylation of GST-She was examined. The results obtained raise 
a possibility that tyrosine phosphorylation of She by c-Src is 
regulated by the interaction between She and PtdIns(4,5)P2. 
2. Materials and methods 
2.1. Materials 
c-Src was purified from bovine brain as described previously [10]. 
Bacto-tryptone and Bacto-yeast extract were purchased from Difco. A 
synthetic tyrosine kinase-substrate peptide, termed Cdc2 peptide, was 
prepared as described [10]. Leupeptin was purchased from Peptide 
Institute (Osaka). (/j-Amidinophenyl)methanesulfonyl fluoride hydro-
chloride was from Wako Pure Chemicals (Osaka). [y-32P]ATP (35020) 
was obtained from ICN. Phosphatidylserine (P-7769), phosphatidyl-
choline (P-5911), and phosphatidic acid (P-9511) were purchased from 
Sigma. Phosphatidylinositol (Ptdlns) (A-38) was obtained from Ser-
dary Research Laboratories. Phosphatidylinositol 4-phosphate 
(PtdIns(4)P) and PtdIns(4,5)P2 were prepared from bovine brain as 
described previously [11]. All the phospholipids were lyophilized from 
the chloroform solution and suspended in distilled water or 20 mM 
Tris-HCl (pH 7.5) by sonication. Mouse NIH 3T3 cell cDNA library 
was purchased from Stratagene. A bacterial expression vector for 
glutathione S-transferase (GST)-fusion protein, pGEX-2T, was 
from Pharmacia Biotech. Other chemicals of analytical grade were 
from Wako or Nacalai (Kyoto). 
2.2. Bacterial expression and purification of GST-fusion She proteins 
DNAs encoding p46, p52 and PTB domain of mouse She were 
obtained by polymerase chain reaction (PCR), using a cDNA library 
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of mouse NIH 3T3 cell as template. The amino acid residues encoded 
by these She constructs were: P46 (46-469), P52 (1-469), and PTB ( 1 -
210) (Fig. 1A). PCR primers used were: the sense primer for P52 and 
PTB, 5'-GTTTGAATTCACATGAACAAGCTGAGTGGA-3'; the 
sense primer for P46, 5'-GTTTGAATTCTCATGGGACCTGGGG-
TTTCCTAC-3'; the antisense primer for PTB, 5'-GAAAGAATT-
CACGGTGGATTCCTGAG-3'; the antisense primer for P52 and 
P46, 5'-GAAAGAATTCACACTTTCCGATCCACGGGTTGCTG-
3'. All the primers contained a restriction site for EcoKl as indicated 
by underlines. After PCR amplification, PCR products were digested 
with EcoRl and ligated into the cognate site of the bacterial expres-
sion plasmid pGEX-2T so that the products were expressed as GST-
fusion proteins. All constructs were confirmed in their orientation, 
length, and sequence by DNA sequencing. 
Cultures of Escherichia coli strain DH5a containing the GST-fu-
sion constructs were grown at 25°C in 300 ml of L-broth (10 mg/ml 
Bacto-tryptone, 5 mg/ml Bacto-yeast extract, 5 mg/ml NaCl) contain-
ing 50 (xg/ml ampicillin. When the A60o reached 0.3, isopropyl-1-thio-
|3-D-galactopyranoside was added to a final concentration of 1.5 mM 
and incubation was continued for an additional 2 h at 25°C. Follow-
ing manipulations were carried out at 4°C. Bacteria were collected by 
centrifugation at 2000 Xg for 5 min, and the pellet was washed with 
250 ml of phosphate-buffered saline. The washed cells were resus-
pended in 10 ml of sonication buffer (20 mM Tris-HCl (pH 8.0), 
1 mM EDTA, 1 mM EGTA, 10 mM P-mercaptoethanol, 10 ug/ml 
leupeptin, 500 u,M (p-amidinophenyl)methanesulfonyl fluoride hydro-
chloride) and sonicated 5 times for 20 s each with TOMY UD-201 
ultrasonic disrupter (Tomy Seiko). The sample was centrifuged at 
15000Xg for 20 min. The supernatant was then loaded onto a col-
umn of 1 ml of glutathione-Sepharose 4B (Pharmacia Biotech) equil-
ibrated with 30 ml of sonication buffer. The column was washed with 
50 ml of sonication buffer containing 0.5 M NaCl. GST-fusion pro-
teins were eluted from the glutathione-Sepharose 4B with 5 ml of 50 
mM Tris-HCl (pH 8.0) containing 5 mM reduced glutathione (Boeh-
ringer Mannheim). Eluted materials were dialyzed against dialysis 
buffer (50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM DTT, 10% 
glycerol) and stored at —80°C until use. One liter each of recombinant 
bacterial cultures yielded 3.46 mg, 0.27 mg, 0.16 mg, and 0.09 mg 
of soluble GST, GST-P46, GST-P52 and GST-PTB, respectively. 
Protein was determined spectrophotometrically with the use of 
Bio-Rad protein assay mixture and bovine serum albumin as a stand-
ard. 
2.3. Protein kinase assay 
Protein kinase assay of c-Src was carried out in the standard reac-
tion mixture (25 u.1) containing 50 mM Tris-HCl (pH 7.5), 5 mM 
MgCl2, 2 uM [y-
32P]ATP (3.7 kBq/pmol), 1 mM dithiothreitol, 2 |xl 
of the purified c-Src fraction (200 ng protein) with or without exog-
enous substrate: 1 mM Cdc2 peptide, 1 u.M GST-p46 or 1 uM GST-
P52. Specific activity of c-Src used in this study was 90 pmol/min/mg 
under the standard kinase assay conditions using 1 mM Cdc2 peptide 
as exogenous substrate [10]. When phosphorylation was examined in 
the presence of various phospholipids, phospholipids and GST-PTB 
or GST were pre-incubated with exogenous substrates at 30°C for 
10 min. The reaction was initiated by the addition of c-Src and 
[y-32P]ATP, proceeded at 30°C for 10 min and terminated by the 
addition of SDS-sample buffer [12] followed by boiling for 3 min. 
When Km was determined for phosphorylation of GST-P46 and 
GST-P52, 20 |0.M [y-32P]ATP (0.37 kBq/pmol) was used instead of 2 
uM ATP. Phosphorylated proteins and Cdc2 peptide were separated 
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) [12] using 
10% and 18% polyacrylamide slab gels, respectively. Gels were stained 
with Coomassie Brilliant Blue to confirm the position of proteins and 
the peptide, and phosphorylated bands were visualized by BAS2000 
Bioimaging Analyzer (Fuji film, Tokyo). To calculate the specific ac-
tivity of phosphate incorporation, the bands were excised from the 
gels and their radioactivity was determined with a liquid scintillation 
counter (Beckman LS 6000IC). 
3. Results and discussion 
To examine the phosphorylation of She by c-Src, GST-
fusion proteins containing 46-kDa (GST-P46) or 52-kDa 
(GST-P52) isoform of She and PTB domain of She (GST-
PTB) were designed to be expressed in bacteria (Fig. 1A). 
Preparations of GST-fusion proteins used in this study were 
analyzed by SDS-PAGE followed by protein staining with 
Coomassie Brilliant Blue (Fig. IB). GST-P46 (lane 1), 
GST-P52 (lane 2), and GST-PTB (lane 3) migrated as the 
proteins of 73 kDa, 78 kDa, and 50 kDa, respectively. Prep-
aration of GST-P52 occasionally displayed degradation prod-
Fig. 1. Preparation of mouse p52shc, p46shc, and She PTB domain as GST-fusion proteins. Schematic representation (A) and Coomasie Brilliant 
Blue-stained SDS-PAGE (B) of the preparations of GST-fusion proteins used in this study are shown. Preparation of cDNAs for each con-
struct and its bacterial expression and purification were carried out as described in Section 2. A: Calculated molecular mass of each GST-fu-
sion protein is shown in parentheses. p52shc (P52) and p46shc (P46) result from differential translation initiation at two proximal ATG sites 
which correspond to methionine 1 and methionine 46 of P52, respectively. Three domains of She are shown: amino-terminal phospho-tyrosine-
binding domain (PTB), collagen-homologous domain (CH), and the carboxyl-terminal Src homology 2 domain (SH2). The major phosphoryla-
tion site in human She [17], Tyr317 (Y317), is also indicated. Mouse She has a deletion of four amino acids before Tyr317 [18], thus correct resi-
due number for the tyrosine phosphorylation site is 313. B: 1 ixg of each preparation of GST-fusion protein was analyzed by SDS-PAGE. Pre-
stained molecular size markers (Bio-Rad); (3-galactosidase (120 kDa), bovine serum albumin (85 kDa), ovalbumin (50.9 kDa), and carbonic 
anhydrase (34 kDa). 
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ucts at 52 kDa (lane 2) and 26 kDa (not shown here), suggest-
ing a proteolytic cleavage around the junction of GST (26 
kDa) and P52. 
First, we examined the phosphorylation of GST-P46 and 
GST-P52 by c-Src under the standard assay conditions. How-
ever, phosphorylation of the GST-She proteins could not be 
detected in spite of the fact that Cdc2 peptide, a synthetic 
peptide substrate, was effectively phosphorylated (data not 
shown). Zhou et al. have demonstrated that PtdIns(4,5)P2 
and PtdIns(4)P specifically bind to the PTB domain of She 
while other phosphohpids such as phosphatidylserine, phos-
phatidic acid, phosphatidylcholine, phosphoethanolamine and 
phosphatidylinositol (Ptdlns) do not [9]. In addition, De 
Corte et al. have recently demonstrated that gelsolin, a known 
PtdIns(4,5)P2-binding protein, can be phosphorylated by c-
Src in a PtdIns(4,5)P2-dependent manner [13]. These observa-
tions led us to think that PtdIns(4,5)P2 binding to the PTB 
domain may alter the structure of She as a substrate of c-Src. 
In Fig. 2, effect of various phosphohpids on the phosphoryl-
ation of 1 uM of GST-P46 or GST-P52 by c-Src was exam-
ined. As control experiments, autophosphorylation and phos-
phorylation of Cdc2 peptide by c-Src were also examined in 
the presence of phosphohpids. Phosphohpids used were phos-
phatidylserine, phosphatidylcholine, phosphatidic acid, 
Ptdlns, PtdIns(4)P, and PtdIns(4,5)P2. All the phosphohpids, 
except phosphatidylcholine and PtdIns(4,5)P2, were found to 
stimulate the c-Src activity as judged by the autophosphoryl-
ation and Cdc2 peptide phosphorylation (lanes 1-3 and 4-6). 
Correspondingly, in the presence of these phosphohpids, 
phosphorylation of GST-She was also stimulated (lanes 7-9 
and 10-12). Therefore, it is concluded that these abundant 
phosphohpids act on c-Src rather than substrate proteins or 
peptide. It has been demonstrated that She is constitutively 
tyrosine-phosphorylated in Rous sarcoma virus-transformed 
cells [14]. It means that deregulated and fully active v-Src 
can phosphorylate She efficiently. Thus, it is possible to think 
that some phosphohpids, which exist abundantly in the plas-
ma membrane, can activate c-Src and enable it to phospho-
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Phospholipid 
PS 
Auto 
0.1 1 10 
Cdc2 peptide 
0.1 1 10 
GST-P46 GST-P52 
0.1 1 10 0.1 1 10 (MM) 
PC 
PA 
PI 
PIP 
PIP2 
1 2 3 4 5 6 7 8 9 10 11 12 
Fig. 2. Effect of various phosphohpids on autophosphorylation of c-Src and phosphorylation of Cdc2 peptide and GST-She by c-Src. Auto-
phosphorylation of c-Src (lanes 1-3), and phosphorylation of Cdc2 peptide (lanes 4-6), GST-P46 (lanes 7-9) and GST-P52 (lanes 10-12) by c-
Src were examined in the presence of 0.1 (J.M (lanes 1, 4, 7, and 10), 1 uM (lanes 2, 5, 8, and 11) or 10 uM (lanes 3, 6, 9, and 12) of various 
phosphohpids in the standard reaction mixture as described in Section 2. Phosphorylated proteins were separated by SDS-PAGE using 10% 
polyacrylamide gels and analyzed by BAS2000 Bioimaging Analyzer. Phosphorylation of Cdc2 peptide was analyzed by SDS-PAGE on 18% 
gels. Results are representative of three independent experiments. PS, phosphatidylserine; PC, phosphatidylcholine; PA, phosphatidic acid; PI, 
Ptdlns; PIP, PtdIns(4)P; PIP2, PtdIns(4,5)P2. 
K. Sato et al.lFEBS Letters 410 (1997) 136-140 139 
10uMPIP2 
GST-PTB (^ M) 
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Fig. 3. She PTB domain inhibits the PtdIns(4,5)P2-dependent phosphorylation of GST-Shc by c-Src. Phosphorylation of GST-P46 (upper pan-
el) and GST-P52 (lower panel) by c-Src was carried out in the absence (lane 1) or the presence (lanes 2-8) of 10 uM PtdIns(4,5)P2 and various 
concentrations (0.1 uM, 1 H-M, 10 uM) of GST-PTB (lanes 3-5) or GST (lanes 6-8). Results are representative of two independent experi-
ments. Phosphoimage of GST-P46 and GST-P52 is shown. 
rylate She proteins. On the other hand, PtdIns(4,5)P2 gave an 
increased phosphorylation of GST-Shc without any effect on 
the c-Src activity itself (Fig. 2, bottom panels). Since GST 
could not be phosphorylated by c-Src at any concentrations 
of phospholipids tested (data not shown), the result suggests 
that PtdIns(4,5)P2 specifically acts on She to interact with c-
Src as a substrate and/or stabilizes a c-Src-Shc complex. Ex-
tent of phosphorylation of GST-P52 was apparently lower 
than that of GST-P46 at about two-times difference (Fig. 2, 
bottom panels). However, it was found that phosphorylation 
of 52-kDa protein, a possible She fragment derived from 
GST-P52 (Fig. IB), is also taking place at an extent compar-
able to GST-P52 (data not shown). Thus, it can be said that 
PtdIns(4,5)P2 stimulates phosphorylation of both p46 and p52 
isoforms of She by c-Src almost equally. Calculated Km values 
for GST-P46 and GST-P52 were 90 nM and 85 nM, respec-
tively, in the presence of 1 uM PtdIns(4,5)P2. Similar values 
were obtained with 10 (J.M PtdIns(4,5)P2; however, higher 
concentration of PtdIns(4,5)P2 (100 uM) greatly inhibited 
the c-Src activity judged by the phosphorylation of Cdc2 pep-
tide (data not shown). These results are quite different from 
the observation by De Corte et al. [13] that the phosphoryla-
tion of gelsolin at 2.5 uM by c-Src required the PtdIns(4,5)P2 
concentration at around 100 uM. 
Since PTB domain of She is shown to bind PtdIns(4,5)P2 
[9], we next examined whether the PtdIns(4,5)P2-dependent 
She phosphorylation by c-Src is affected by exogenously 
added PTB domain. As shown in Fig. 3, GST-PTB inhibited 
the phosphorylation of GST-Shc in a dose-dependent man-
ner, while GST did not. GST-PTB could not be a substrate of 
c-Src at any concentrations used in this study (data not 
shown), indicating that the inhibition was not a result of sub-
strate competition. The result seems to be consistent with the 
idea that She PTB domain competitively binds to 
PtdIns(4,5)P2 and abolishes GST-Shc phosphorylation by c-
Src. However, it may be an oversimplified interpretation. In-
terestingly, 1 uM GST-PTB showed significant inhibitory ef-
fect toward 10 uM PtdIns(4,5)P2 (Fig. 3, lane 4) and 10 uM 
GST-PTB was enough for the complete inhibition (lane 5). 
Such effect at low molar ratio cannot be explained by a simple 
competitive interaction. Therefore, it might be possible that 
GST-PTB also binds to c-Src and interferes with the interac-
tion between c-Src and GST-Shc. 
In this study, PtdIns(4,5)P2 was shown to stimulate the 
phosphorylation of GST-Shc by c-Src. Relative content of 
PtdIns(4,5)P2 among phospholipids in the plasma membrane 
is quite low and strictly regulated by extracellular stimuli 
elicited by hormones and environmental conditions. So, it is 
suggested that PtdIns(4,5)P2 can act as a regulator for the 
phosphorylation of She by c-Src in an extracellular signal-
dependent manner. It is well established that tyr317 of She is 
the major site of phosphorylation and the phosphorylation is 
indispensable for She-dependent signaling pathways [2-5]. 
However, it is not clear whether the same tyrosine residue is 
phosphorylated in the presence of PtdIns(4,5)P2. It should be 
clarified whether tyr317 is the only phosphorylation site in the 
PtdIns(4,5)P2-treated She. It is also of interest whether the 
products of a lipid kinase PI 3-kinase such as PtdIns(3,4,5)P3 
affects the She phosphorylation by c-Src because involvement 
of PI 3-kinase in the kinase/non-kinase receptor-mediated ty-
rosine phosphorylation of She has been documented [15,16]. 
As it can be concluded from the results shown in Fig. 3, the 
interaction of PtdIns(4,5)P2 with PTB domain is required for 
the PtdIns(4,5)P2-dependent phosphorylation of She by c-Src. 
It seems natural to surmise that the interaction between 
PtdIns(4,5)P2 and She PTB domain serves not only for local-
izing She to the membrane as anticipated [9] but also for 
modulating the tyrosine phosphorylation of She. However, 
it is also possible that PtdIns(4)P, which has been shown to 
bind to PTB domain of She [9], can act as a modulator for 
tyrosine phosphorylation of She although PtdIns(4)P stimu-
lated the c-Src activity itself in our experimental system (Fig. 
2). It has been demonstrated that binding of PtdIns(4,5)P2 to 
PTB domain can be eliminated partially by a phosphotyro-
sine-containing peptide [9]. Thus, it would be interesting to 
test whether such phosphotyrosine-binding to the PTB do-
main also affects the phosphorylation of She by c-Src. In 
the presence of PtdIns(4,5)P2, phosphorylation of both 
GST-P46 and GST-P52 was equally stimulated. In many 
cell systems, however, the extent of expression and phospho-
140 
rylation level of these two isoforms are quite different. Thus, 
the elucidation of the function of each She isoform may con-
tribute to the understanding the signal transduction pathways 
involving She. 
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